Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letrozole and Celecoxib in Advanced Breast Cancer
NCT00101062Phase 2Terminated
- Sponsor
- University of Medicine and Dentistry of New Jersey
- Start
- Jan 2004
- Primary completion
- Dec 2005
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of celecoxib in breast cancer, sponsored by University of Medicine and Dentistry of New Jersey. Started Jan 2004; status: terminated.
02
Drugs
celecoxib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00101062.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00101062.